Welcome to FLUotech biosciences

In Pursuit of Better Health Solutions

FluoTech Biosciences is at the forefront of developing advanced therapeutic solutions for cardiovascular diseases, particularly atherosclerosis. Our proprietary FTB-728 nanoparticle platform offers unparalleled drug-loading capacity and precise targeting, revolutionizing how we approach disease treatment.

Products
0
Patents
0
Employees
0
Countries*
0
Our Company

Fast Growing Bio-Tech Company

FluoTech Biosciences is a rapidly expanding biotechnology company dedicated to transforming healthcare through cutting-edge nanomaterial technologies. Founded in April 2024, we have established robust partnerships with leading institutions and secured funding from HKTECH300, Hong Kong’s premier technology startup program. 

At FluoTech, we’re revolutionizing cardiovascular treatment with our FTB-728 platform — combining innovation, precision, and sustainability to fight atherosclerosis and empower researchers globally.

Mohamed el. hilal

Founder, CEO of Fluotech Biosciences Limited

Our Values

Driven by Discovery. United in Purpose.

01.
Innovation

We continuously push the boundaries of science to develop groundbreaking solutions.

02.
Teamwork

Together, we achieve more by leveraging the expertise of our team and partners.

03.
Sustainable

We are committed to sustainable practices in all aspects of our operations, ensuring minimal environmental impact.

04.
Integrity

Transparency and honesty guide our interactions with stakeholders, partners, and the community.

05.
Excellence

We strive for excellence in every aspect of our work, from research and development to commercialization.

06.
Commitment

We are deeply committed to improving global health and advancing scientific discovery.

Our Products

Committed to Quality

At FluoTech Biosciences, quality is at the heart of everything we do. We are dedicated to delivering safe, effective, and reliable nanomaterial solutions that meet the highest industry standards.

Clinical Development

Targeted drug delivery with FTB-728 for precise, effective therapies.

Regulatory & Access

Navigating global standards to ensure compliance and accelerate patient access.

Biotech

Transforming cardiovascular treatment through advanced nanotechnology solutions.

Functional Service

Supporting research and clinical applications with reliable, scalable services.

Our Purpose

We are committed to excellence and development of cutting-edge solutions.

FluoTech Biosciences is dedicated to transforming cardiovascular health through innovative nanomaterial solutions. Our mission is to address critical global health challenges.

At FluoTech, we are committed to delivering breakthrough technologies like our proprietary FTB-728 nanoparticle platform, which offers unparalleled drug-loading capacity and precise targeting capabilities as well as ATHRICINE. This dual-purpose technology serves both as a research tool and a therapeutic solution.

Our Collaborations